vs
德康医疗（DXCM）与豪士科（OSK）财务数据对比。点击上方公司名可切换其他公司
豪士科的季度营收约是德康医疗的1.8倍（$2.3B vs $1.3B），德康医疗净利率更高（21.2% vs 1.9%，领先19.4%），德康医疗同比增速更快（21.6% vs 0.2%），过去两年德康医疗的营收复合增速更高（12.0% vs -9.8%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
豪士科（原称豪士科卡车）是美国知名工业企业，主营特种卡车、军用车辆、机场消防设备、高空作业设备等产品的设计与制造。旗下拥有威斯康星州的消防车制造商Pierce Manufacturing，以及生产各类升降作业设备的JLG工业公司。
DXCM vs OSK — 直观对比
营收规模更大
OSK
是对方的1.8倍
$1.3B
营收增速更快
DXCM
高出21.4%
0.2%
净利率更高
DXCM
高出19.4%
1.9%
两年增速更快
DXCM
近两年复合增速
-9.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $2.3B |
| 净利润 | $267.3M | $43.1M |
| 毛利率 | 62.9% | 13.5% |
| 营业利润率 | 25.6% | 3.5% |
| 净利率 | 21.2% | 1.9% |
| 营收同比 | 21.6% | 0.2% |
| 净利润同比 | 153.6% | -61.6% |
| 每股收益（稀释后） | $0.67 | $0.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMOSK
| Q1 26 | $1.3B | $2.3B | ||
| Q4 25 | $1.3B | $2.7B | ||
| Q3 25 | $1.2B | $2.7B | ||
| Q2 25 | $1.2B | $2.7B | ||
| Q1 25 | $1.0B | $2.3B | ||
| Q4 24 | $1.1B | $2.6B | ||
| Q3 24 | $994.2M | $2.7B | ||
| Q2 24 | $1.0B | $2.8B |
净利润DXCMOSK
| Q1 26 | $267.3M | $43.1M | ||
| Q4 25 | $267.3M | $133.8M | ||
| Q3 25 | $283.8M | $196.2M | ||
| Q2 25 | $179.8M | $204.8M | ||
| Q1 25 | $105.4M | $112.2M | ||
| Q4 24 | $151.7M | $153.1M | ||
| Q3 24 | $134.6M | $180.3M | ||
| Q2 24 | $143.5M | $168.6M |
毛利率DXCMOSK
| Q1 26 | 62.9% | 13.5% | ||
| Q4 25 | 62.9% | 15.8% | ||
| Q3 25 | 60.5% | 17.5% | ||
| Q2 25 | 59.5% | 19.2% | ||
| Q1 25 | 56.9% | 17.3% | ||
| Q4 24 | 58.9% | 17.2% | ||
| Q3 24 | 59.7% | 18.5% | ||
| Q2 24 | 62.4% | 19.2% |
营业利润率DXCMOSK
| Q1 26 | 25.6% | 3.5% | ||
| Q4 25 | 25.6% | 7.9% | ||
| Q3 25 | 20.1% | 9.7% | ||
| Q2 25 | 18.4% | 10.7% | ||
| Q1 25 | 12.9% | 7.6% | ||
| Q4 24 | 17.0% | 8.6% | ||
| Q3 24 | 15.3% | 9.7% | ||
| Q2 24 | 15.7% | 9.2% |
净利率DXCMOSK
| Q1 26 | 21.2% | 1.9% | ||
| Q4 25 | 21.2% | 5.0% | ||
| Q3 25 | 23.5% | 7.3% | ||
| Q2 25 | 15.5% | 7.5% | ||
| Q1 25 | 10.2% | 4.9% | ||
| Q4 24 | 13.6% | 5.9% | ||
| Q3 24 | 13.5% | 6.6% | ||
| Q2 24 | 14.3% | 5.9% |
每股收益（稀释后）DXCMOSK
| Q1 26 | $0.67 | $0.68 | ||
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.70 | — | ||
| Q2 25 | $0.45 | — | ||
| Q1 25 | $0.27 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.34 | — | ||
| Q2 24 | $0.35 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $250.3M |
| 总债务越低越好 | — | $600.6M |
| 股东权益账面价值 | $2.7B | — |
| 总资产 | $6.3B | $10.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMOSK
| Q1 26 | $917.7M | $250.3M | ||
| Q4 25 | $917.7M | $479.8M | ||
| Q3 25 | $1.8B | $211.8M | ||
| Q2 25 | $1.2B | $191.7M | ||
| Q1 25 | $904.9M | $210.3M | ||
| Q4 24 | $606.1M | $204.9M | ||
| Q3 24 | $621.2M | $160.9M | ||
| Q2 24 | $939.2M | $141.4M |
总债务DXCMOSK
| Q1 26 | — | $600.6M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $602.3M | ||
| Q2 24 | — | $599.1M |
股东权益DXCMOSK
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $4.5B | ||
| Q3 25 | $2.7B | $4.5B | ||
| Q2 25 | $2.6B | $4.5B | ||
| Q1 25 | $2.3B | $4.2B | ||
| Q4 24 | $2.1B | $4.2B | ||
| Q3 24 | $2.0B | $4.1B | ||
| Q2 24 | $2.4B | $3.9B |
总资产DXCMOSK
| Q1 26 | $6.3B | $10.0B | ||
| Q4 25 | $6.3B | $10.1B | ||
| Q3 25 | $7.5B | $9.8B | ||
| Q2 25 | $7.3B | $10.0B | ||
| Q1 25 | $6.8B | $9.8B | ||
| Q4 24 | $6.5B | $9.4B | ||
| Q3 24 | $6.4B | $9.9B | ||
| Q2 24 | $6.8B | $9.7B |
负债/权益比DXCMOSK
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.15× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
